Gemcitabine Hydrochloride Market Analysis 2034: Key Industry Trends

adicionou um novo artigo Outro

2026-11-06 12:54:07 -

The Gemcitabine Hydrochloride market was valued at US$ 873.1 million in 2025 and is expected to reach US$ 1,297.83 million by 2034. The market is estimated to record a CAGR of 4.5% during 2026–2034. The increasing prevalence of cancer, rising demand for effective chemotherapy medications, growing awareness of early cancer diagnosis, and expanding access to oncology treatments are among...

0 Comentários 0 Compartilhamentos 8 Visualizações 0 Anterior